82 related articles for article (PubMed ID: 9261895)
1. The effects of interferon-alpha on serum lipid peroxidation and total thiol content in patients with chronic active hepatitis-C.
Mutlu-Türkoglu U; Ademoglu E; Türkoglu S; Badur S; Uysal M; Toker G
Res Commun Mol Pathol Pharmacol; 1997 Jun; 96(3):357-61. PubMed ID: 9261895
[TBL] [Abstract][Full Text] [Related]
2. [Oxidative stress and antioxidant defense in alcoholic liver disease and chronic hepatitis C].
Pár A; Róth E; Rumi G; Kovács Z; Nemes J; Mózsik G
Orv Hetil; 2000 Jul; 141(30):1655-9. PubMed ID: 10962902
[TBL] [Abstract][Full Text] [Related]
3. Prospective comparison of four lymphoblastoid interferon alpha schedules for chronic hepatitis C. A multivariate analysis of factors predictive of sustained response to treatment.
Bellobuono A; Mondazzi L; Tempini S; Silini E; Idéo G
Eur J Gastroenterol Hepatol; 1997 Dec; 9(12):1169-77. PubMed ID: 9471022
[TBL] [Abstract][Full Text] [Related]
4. Evolution of hepatitis C virus-specific T cell responses and cytokine production in chronic hepatitis C patients treated with high doses of interferon-alpha.
Alvarado Esquivel C; Elewaut A; Philippé J; Elewaut AE; Desombere I; Maertens G; Leroux-Roels G
Rev Invest Clin; 2002; 54(1):41-50. PubMed ID: 11995406
[TBL] [Abstract][Full Text] [Related]
5. Studies of the effectiveness of interferon alpha treatment for chronic hepatitis C in children.
Czerwionka-Szaflarska M; Chrobot A; Szaflarska-Szczepanik A
Med Sci Monit; 2000; 6(5):964-70. PubMed ID: 11208439
[TBL] [Abstract][Full Text] [Related]
6. Oxidant stress and antioxidant status among patients with nonalcoholic fatty liver disease (NAFLD).
Madan K; Bhardwaj P; Thareja S; Gupta SD; Saraya A
J Clin Gastroenterol; 2006; 40(10):930-5. PubMed ID: 17063114
[TBL] [Abstract][Full Text] [Related]
7. Interferon-alpha enhances biological defense activities against oxidative stress in cultured rat hepatocytes and hepatic stellate cells.
Lu G; Shimizu I; Cui X; Itonaga M; Tamaki K; Fukuno H; Inoue H; Honda H; Ito S
J Med Invest; 2002 Aug; 49(3-4):172-81. PubMed ID: 12323007
[TBL] [Abstract][Full Text] [Related]
8. A randomized study comparing ribavirin and interferon alfa monotherapy for hepatitis C recurrence after liver transplantation.
Gane EJ; Lo SK; Riordan SM; Portmann BC; Lau JY; Naoumov NV; Williams R
Hepatology; 1998 May; 27(5):1403-7. PubMed ID: 9581698
[TBL] [Abstract][Full Text] [Related]
9. Adiponectin: a new independent predictor of liver steatosis and response to IFN-alpha treatment in chronic hepatitis C.
Zografos TA; Liaskos C; Rigopoulou EI; Togousidis E; Makaritsis K; Germenis A; Dalekos GN
Am J Gastroenterol; 2008 Mar; 103(3):605-14. PubMed ID: 18190648
[TBL] [Abstract][Full Text] [Related]
10. Investigation of oxidative stress and some antioxidants in patients with acute and chronic viral hepatitis B and the effect of interferon-alpha treatment.
Dikici I; Mehmetoglu I; Dikici N; Bitirgen M; Kurban S
Clin Biochem; 2005 Dec; 38(12):1141-4. PubMed ID: 16300751
[TBL] [Abstract][Full Text] [Related]
11. Significance of anti-interferon-alpha2 and sICAM-1 activities in the sera of viral hepatitis B and C patients treated with human recombinant interferon-alpha2.
Stancek D; Fuchsberger N; Oltman M; Schmeisser H; Kontsek P; Jahnová E; Hajnická V
Acta Virol; 2001; 45(5-6):287-92. PubMed ID: 12083327
[TBL] [Abstract][Full Text] [Related]
12. Time-dependent effects of ethanol on blood oxidative stress parameters and cytokines.
Das SK; Varadhan S; Gupta G; Mukherjee S; Dhanya L; Rao DN; Vasudevan DM
Indian J Biochem Biophys; 2009 Feb; 46(1):116-21. PubMed ID: 19374264
[TBL] [Abstract][Full Text] [Related]
13. Adenosine deaminase enzyme activity is increased and negatively correlates with catalase, superoxide dismutase and glutathione peroxidase in patients with Behçet's disease: original contributions/clinical and laboratory investigations.
Erkiliç K; Evereklioglu C; Cekmen M; Ozkiris A; Duygulu F; Dogan H
Mediators Inflamm; 2003 Apr; 12(2):107-16. PubMed ID: 12775361
[TBL] [Abstract][Full Text] [Related]
14. Plasmatic vitamin C in nontreated hepatitis C patients is negatively associated with aspartate aminotransferase.
Souza dos Santos RM; de Bem AF; Colpo E; Bertoncello I; Nogueira CW; Rocha JB
Liver Int; 2008 Jan; 28(1):54-60. PubMed ID: 17927712
[TBL] [Abstract][Full Text] [Related]
15. Phase II clinical trial of combined natural interferon-beta plus recombinant interferon-gamma treatment of chronic hepatitis B.
Musch E; Högemann B; Gerritzen A; Fischer HP; Wiese M; Kruis W; Malek M; Gugler R; Schmidt G; Huchzermeyer H; Gerlach U; Dengler HJ; Sauerbruch T
Hepatogastroenterology; 1998; 45(24):2282-94. PubMed ID: 9951911
[TBL] [Abstract][Full Text] [Related]
16. Is interferon-alpha therapy safe and effective for patients with chronic hepatitis C and inflammatory bowel disease? A case-control study.
Bargiggia S; Thorburn D; Anderloni A; Ardizzone S; Giorgi A; Bianchi Porro G; Parente F
Aliment Pharmacol Ther; 2005 Aug; 22(3):209-15. PubMed ID: 16091058
[TBL] [Abstract][Full Text] [Related]
17. Hepatitis C virus dynamics in vivo: effect of ribavirin and interferon alfa on viral turnover.
Zeuzem S; Schmidt JM; Lee JH; von Wagner M; Teuber G; Roth WK
Hepatology; 1998 Jul; 28(1):245-52. PubMed ID: 9657119
[TBL] [Abstract][Full Text] [Related]
18. High dosage of ascorbic acid and alpha-tocopherol is not useful for diminishing oxidative stress and DNA damage in healthy elderly adults.
Retana-Ugalde R; Casanueva E; Altamirano-Lozano M; González-Torres C; Mendoza-Núñez VM
Ann Nutr Metab; 2008; 52(2):167-73. PubMed ID: 18446021
[TBL] [Abstract][Full Text] [Related]
19. Alpha-interferon with ribavirin in the treatment of hemodialysis patients with hepatitis C.
Mousa DH; Abdalla AH; Al-Shoail G; Al-Sulaiman MH; Al-Hawas FA; Al-Khader AA
Transplant Proc; 2004; 36(6):1831-4. PubMed ID: 15350490
[TBL] [Abstract][Full Text] [Related]
20. Diphenyl diselenide, a simple organoselenium compound, decreases methylmercury-induced cerebral, hepatic and renal oxidative stress and mercury deposition in adult mice.
de Freitas AS; Funck VR; Rotta Mdos S; Bohrer D; Mörschbächer V; Puntel RL; Nogueira CW; Farina M; Aschner M; Rocha JB
Brain Res Bull; 2009 Apr; 79(1):77-84. PubMed ID: 19047014
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
